Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid … – UroToday
|
Efficacy and safety of chimeric antigen receptor T–cell (CAR-T) therapy in patients with haematological and solid …
UroToday Patients with relapsed or refractory malignancies have a poor prognosis. Immunotherapy with chimeric antigen receptor T (CAR–T) cells redirects a patient's immune cells against the tumour antigen. CAR–T cell therapy has demonstrated promise in treating … |
